{
  "forecastId": "37657-sonnet-full",
  "questionId": 37657,
  "model": "sonnet",
  "infoLabel": "full",
  "instance": null,
  "information": "A novel bat coronavirus, HKU5-CoV-2, has been identified and is part of the Merbecovirus family, which includes the MERS virus. Research published in the journal 'Cell' confirms that the virus can bind to human ACE2 receptors and infect human airway and organoid cultures in laboratory settings. However, studies also indicate that its cell-entry efficiency is significantly lower than that of SARS-CoV-2.\n\nAs of May 16, 2025, no human cases of HKU5-CoV-2 have been reported by any major global health organizations, including the WHO, US CDC, ProMED, or GISAID. Post-COVID surveillance systems are in place in several countries, including China, Korea, and the U.S., which involve routine metagenomic sequencing of severe acute respiratory infection (SARI) cases. To date, these surveillance efforts have not detected any signals of HKU5-CoV-2 in human populations.\n\nHistorically, of the approximately 50 novel bat coronaviruses described in scientific literature since 2000, only SARS-CoV and SARS-CoV-2 have produced confirmed human cases within a year of their first description. The rate of publicly reported accidental laboratory infections for such viruses is also low, estimated at approximately one per decade worldwide.",
  "forecast": {
    "time_left_until_outcome_known": "Approximately 46 days, from May 16, 2025 to July 1, 2025",
    "status_quo_outcome": "NO - No human cases of HKU5-CoV-2 have been reported to date, and if current conditions persist, none will be reported before July 1, 2025",
    "no_outcome_scenario": "The virus remains confined to bat populations without any spillover events. Laboratory researchers maintain proper biosafety protocols. The virus's demonstrated lower cell-entry efficiency compared to SARS-CoV-2 prevents natural transmission. Robust post-COVID surveillance systems continue monitoring but detect no human cases through July 1, 2025",
    "yes_outcome_scenario": "Either a natural spillover event occurs from bats to humans in an endemic area, or a laboratory accident leads to human exposure during research activities. The case is detected by surveillance systems and reported by WHO, CDC, or other credible health organizations before July 1, 2025",
    "rationale": "The extremely short timeframe of 46 days is the dominant factor in this forecast. The status quo strongly favors NO: despite HKU5-CoV-2 being identified and characterized, no human cases have been reported. Historical base rates support this: only 2 of approximately 50 novel bat coronaviruses described since 2000 (SARS-CoV and SARS-CoV-2) caused confirmed human cases within a year of description, representing a 4% annual rate. Adjusting for the 46-day timeframe (12.6% of a year), natural spillover probability would be approximately 0.5%. Laboratory accidents add minimal additional risk, estimated at roughly 1 per decade globally for such viruses. However, several factors prevent an even lower forecast. The virus has demonstrated capability to bind human ACE2 receptors and infect human airway cells in laboratory settings, confirming biological plausibility. Active research creates some exposure risk, though modern biosafety protocols mitigate this. Post-COVID surveillance systems are robust and would likely detect cases if they occurred, increasing detection probability relative to historical baselines. The key evidence from the research assistant that no surveillance signals have been detected through May 16, 2025 is reassuring, but 46 days remains sufficient time for a case to emerge and be reported. My forecast is not higher because: the timeframe is very short, historical spillover rates are low, cell-entry efficiency is documented as lower than SARS-CoV-2, and no cases have been detected despite the virus being known. My forecast is not lower because: biological plausibility of human infection is established, surveillance quality could enable rapid detection if cases occur, and there remains non-zero risk from both natural and laboratory exposure. To update upward, I would need: reports of suspected cases, laboratory exposure incidents, or surveillance signals. To update downward: each day that passes without reports reduces the remaining probability proportionally",
    "probability": 3
  },
  "prompt": "You are a professional forecaster interviewing for a job.\n\nYour interview question is:\nWill there be any human cases of the novel coronavirus, HKU5-CoV-2, before July 1, 2025?\n\nQuestion background:\n[Discovery of HKU5-CoV-2, a Novel Coronavirus in China](https://assure-test.com/discovery-of-hku5-cov-2-a-novel-coronavirus-in-china/)\n\n\nThis question's outcome will be determined by the specific criteria below. These criteria have not yet been satisfied:\nThis question resolves as **Yes** if before July 1, 2025, there are any human cases reported anywhere globally of HKU5-CoV-2.\n\nQuestion resolves according to [credible sources](https://www.metaculus.com/help/faq/#definitions), especially the World Health Organization or US Centers for Disease Control.\n\n\nYour research assistant's report says:\nA novel bat coronavirus, HKU5-CoV-2, has been identified and is part of the Merbecovirus family, which includes the MERS virus. Research published in the journal 'Cell' confirms that the virus can bind to human ACE2 receptors and infect human airway and organoid cultures in laboratory settings. However, studies also indicate that its cell-entry efficiency is significantly lower than that of SARS-CoV-2.\n\nAs of May 16, 2025, no human cases of HKU5-CoV-2 have been reported by any major global health organizations, including the WHO, US CDC, ProMED, or GISAID. Post-COVID surveillance systems are in place in several countries, including China, Korea, and the U.S., which involve routine metagenomic sequencing of severe acute respiratory infection (SARI) cases. To date, these surveillance efforts have not detected any signals of HKU5-CoV-2 in human populations.\n\nHistorically, of the approximately 50 novel bat coronaviruses described in scientific literature since 2000, only SARS-CoV and SARS-CoV-2 have produced confirmed human cases within a year of their first description. The rate of publicly reported accidental laboratory infections for such viruses is also low, estimated at approximately one per decade worldwide.\n\nToday is 2025-05-16.\n\nBefore answering you think:\n(a) The time left until the outcome to the question is known.\n(b) The status quo outcome if nothing changed.\n(c) A brief description of a scenario that results in a No outcome.\n(d) A brief description of a scenario that results in a Yes outcome.\n(e) You write your rationale remembering that good forecasters put extra weight on the status quo outcome since the world changes slowly most of the time. Explain your reasoning and the evidence behind your forecast in detail. Summarise information your received from your research assistant that influences your forecast (if any). Explain why your forecast is not higher, and why it is not lower. Outline what would need to be true for you to update your forecast in either direction.\n(f) The last thing you write is your final probabilistic forecast as a number between 0 and 100.\n\n# OUTPUT SCHEMA\n{\n    \"time_left_until_outcome_known\": \"string\",\n    \"status_quo_outcome\": \"string\",\n    \"no_outcome_scenario\": \"string\",\n    \"yes_outcome_scenario\": \"string\",\n    \"rationale\": \"string\",\n    \"probability\": \"number\" (0-100)\n}"
}